§Weight LossResearch protocol
AICAR.
AICAR (5-aminoimidazole-4-carboxamide ribonucleoside) is a research compound that activates AMP-activated protein kinase (AMPK)[1], earning the nickname “exercise pill” after studies showed sedenta...
Research Use Only. PeptiJournal supports private research documentation and calculation support. It does not provide medical advice, human-use directions, or claims of safety or effectiveness.
Cited diluent3 mL
Cited protocol example—review and confirm.
Reference syringe capacity
Concentration
16,666.667
mcg/mL
Per event
1 mg
7 events/week
Vials projected
3
8 cited weeks
Calculated volume reference
6.0 units
1mL syringe
AICAR
6.0u(0.060 mL)
Daily
Cited protocol & reconstitution guide
Source-backed reference fields by phase, including any volume fields authored in the cited guide.
Weeks 1–2
1,000 mcg (1 mg)
Units / volume6 units (0.06 mL)
Weeks 3–4
2,000 mcg (2 mg)
Units / volume12 units (0.12 mL)
Weeks 5–8
3,000 mcg (3 mg)
Units / volume18 units (0.18 mL)
| Phase | Daily reference amount | Units / volume |
|---|---|---|
| Weeks 1–2 | 1,000 mcg (1 mg) | 6 units (0.06 mL) |
| Weeks 3–4 | 2,000 mcg (2 mg) | 12 units (0.12 mL) |
| Weeks 5–8 | 3,000 mcg (3 mg) | 18 units (0.18 mL) |
Cited guide source: View source